As of the latest Form 4 filed Jun 12, 2026.
What Johnson & Johnson insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 16 most recent filings for JNJ.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | 2026-06-11 | Wengel Kathryn E EVP, Chief TO and Risk Officer | SSale | −10.0K | $241.15 | $2.41M | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-11 | Wengel Kathryn E, EVP, Chief TO and Risk Officer | MExercise | +10.0K | $115.67 | $1.16M | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | REED JOHN C EVP, Innovative Medicine, R&D | FTax | −11.0K | $229.85 | $2.53M | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | REED JOHN C, EVP, Innovative Medicine, R&D | MExercise | +25.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Schmid Timothy EVP, WW Chair, MedTech | FTax | −10.3K | $239.99 | $2.48M | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-06 | Schmid Timothy, EVP, WW Chair, MedTech | MExercise | +15.6K | $101.87 | $1.59M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | Mulholland Kristen EVP, Chief HR Officer | FTax | −3.33K | $239.99 | $800K | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | Mulholland Kristen, EVP, Chief HR Officer | MExercise | +5.63K | $101.87 | $573K | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | Wengel Kathryn E EVP, Chief TO and Risk Officer | FTax | −27.3K | $239.99 | $6.54M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | Wengel Kathryn E, EVP, Chief TO and Risk Officer | MExercise | +38.9K | $101.87 | $3.97M | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-05 | Forminard Elizabeth EVP, Chief Legal Officer | FTax | −6.23K | $237.90 | $1.48M | No | Form 4 ↗ |
| 2026-02-06 | 2026-02-05 | Forminard Elizabeth, EVP, Chief Legal Officer | MExercise | +8.92K | $129.51 | $1.16M | No | Form 4 ↗ |
| 2026-01-28 | 2026-01-26 | Duato Joaquin CEO and Chairman of the Board | SSale | −48.8K | $221.48 | $10.8M | No | Form 4 ↗ |
| 2026-01-28 | 2026-01-26 | Duato Joaquin, CEO and Chairman of the Board | SSale | −51.2K | $220.99 | $11.3M | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | REED JOHN C EVP, Innovative Medicine, R&D | FTax | −11.0K | $144.59 | $1.59M | No | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | REED JOHN C, EVP, Innovative Medicine, R&D | MExercise | +22.3K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also JNJ’s full analysis or the market-wide insider trading feed. The tabs above jump to JNJ’s other SEC data.
Source: SEC Form 4 filings for JNJ, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.